1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Patel, P.
Clarke, C.J.
Barraclough, D.L.
Rudland, P.S.
Barraclough, R.
Lian, L.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
UK
J.Mol.Biol.
JMOBAK
0070
0022-2836
425
929
943
10.1016/j.jmb.2012.12.009
23274113
Metastasis-promoting anterior gradient 2 protein has a dimeric thioredoxin fold structure and a role in cell adhesion.
2013
10.2210/pdb2lnt/pdb
pdb_00002lnt
16130.548
Anterior gradient protein 2 homolog
UNP residues 41-175
E60A
1
man
polymer
AG-2, hAG-2, HPC8, Secreted cement gland protein XAG-2 homolog
no
no
IDPFTPQTLSRGWGDQLIWTQTYEAALYKSKTSNKPLMIIHHLDECPHSQALKKVFAENKEIQKLAEQFVLLNLVYETTD
KHLSPDGQYVPRIMFVDPSLTVRADITGRYSNRLYAYEPADTALLLDNMKKALKLLKTEL
IDPFTPQTLSRGWGDQLIWTQTYEAALYKSKTSNKPLMIIHHLDECPHSQALKKVFAENKEIQKLAEQFVLLNLVYETTD
KHLSPDGQYVPRIMFVDPSLTVRADITGRYSNRLYAYEPADTALLLDNMKKALKLLKTEL
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
sample
AGR2, AG2, UNQ515/PRO1030
9606
Homo sapiens
562
Escherichia coli
pET-151D
database_2
pdbx_database_status
pdbx_nmr_software
pdbx_nmr_spectrometer
struct_ref_seq_dif
repository
Initial release
Database references
Database references
Data collection
Database references
Other
1
0
2013-01-09
1
1
2013-01-30
1
2
2013-03-06
1
3
2023-06-14
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_database_status.status_code_nmr_data
_pdbx_nmr_software.name
_pdbx_nmr_spectrometer.model
_struct_ref_seq_dif.details
BMRB
Y
RCSB
2012-01-04
REL
REL
REL
REL
structures with the lowest energy
200
10
2D 1H-15N HSQC
2D 1H-13C HSQC
3D HNCA
3D HN(CO)CA
3D HNCACB
3D CBCA(CO)NH
3D HNCO
3D 1H-13C NOESY
3D 1H-15N NOESY
3D HN(CA)CO
IPAP
3D HBHA(CO)NH
3D HBHANH
0.3
mM
[U-13C; U-15N]
0.3
mM
[U-15N]
10
mg/mL
0.1
6.5
ambient
298
K
simulated annealing, refinement
1
lowest energy
0.3 mM [U-13C; U-15N] AGR2 E60A, 90% H2O/10% D2O
90% H2O/10% D2O
0.3 mM [U-15N] AGR2 E60A, 10 mg Pf1 phage, 90% H2O/10% D2O
90% H2O/10% D2O
Brunger, Adams, Clore, Gros, Nilges and Read
structure solution
CNSSOLVE
CCPN
peak picking
Analysis
CCPN
chemical shift assignment
Analysis
Schwieters, Kuszewski, Tjandra and Clore
refinement
X-PLOR NIH
Bruker Biospin
collection
TopSpin
Bruker Biospin
processing
TopSpin
Brunger, Adams, Clore, Gros, Nilges and Read
refinement
CNSSOLVE
600
Bruker
AVANCE
Bruker Avance
800
Bruker
AVANCE
Bruker Avance
ILE
36
n
1
ILE
36
A
ASP
37
n
2
ASP
37
A
PRO
38
n
3
PRO
38
A
PHE
39
n
4
PHE
39
A
THR
40
n
5
THR
40
A
PRO
41
n
6
PRO
41
A
GLN
42
n
7
GLN
42
A
THR
43
n
8
THR
43
A
LEU
44
n
9
LEU
44
A
SER
45
n
10
SER
45
A
ARG
46
n
11
ARG
46
A
GLY
47
n
12
GLY
47
A
TRP
48
n
13
TRP
48
A
GLY
49
n
14
GLY
49
A
ASP
50
n
15
ASP
50
A
GLN
51
n
16
GLN
51
A
LEU
52
n
17
LEU
52
A
ILE
53
n
18
ILE
53
A
TRP
54
n
19
TRP
54
A
THR
55
n
20
THR
55
A
GLN
56
n
21
GLN
56
A
THR
57
n
22
THR
57
A
TYR
58
n
23
TYR
58
A
GLU
59
n
24
GLU
59
A
ALA
60
n
25
ALA
60
A
ALA
61
n
26
ALA
61
A
LEU
62
n
27
LEU
62
A
TYR
63
n
28
TYR
63
A
LYS
64
n
29
LYS
64
A
SER
65
n
30
SER
65
A
LYS
66
n
31
LYS
66
A
THR
67
n
32
THR
67
A
SER
68
n
33
SER
68
A
ASN
69
n
34
ASN
69
A
LYS
70
n
35
LYS
70
A
PRO
71
n
36
PRO
71
A
LEU
72
n
37
LEU
72
A
MET
73
n
38
MET
73
A
ILE
74
n
39
ILE
74
A
ILE
75
n
40
ILE
75
A
HIS
76
n
41
HIS
76
A
HIS
77
n
42
HIS
77
A
LEU
78
n
43
LEU
78
A
ASP
79
n
44
ASP
79
A
GLU
80
n
45
GLU
80
A
CYS
81
n
46
CYS
81
A
PRO
82
n
47
PRO
82
A
HIS
83
n
48
HIS
83
A
SER
84
n
49
SER
84
A
GLN
85
n
50
GLN
85
A
ALA
86
n
51
ALA
86
A
LEU
87
n
52
LEU
87
A
LYS
88
n
53
LYS
88
A
LYS
89
n
54
LYS
89
A
VAL
90
n
55
VAL
90
A
PHE
91
n
56
PHE
91
A
ALA
92
n
57
ALA
92
A
GLU
93
n
58
GLU
93
A
ASN
94
n
59
ASN
94
A
LYS
95
n
60
LYS
95
A
GLU
96
n
61
GLU
96
A
ILE
97
n
62
ILE
97
A
GLN
98
n
63
GLN
98
A
LYS
99
n
64
LYS
99
A
LEU
100
n
65
LEU
100
A
ALA
101
n
66
ALA
101
A
GLU
102
n
67
GLU
102
A
GLN
103
n
68
GLN
103
A
PHE
104
n
69
PHE
104
A
VAL
105
n
70
VAL
105
A
LEU
106
n
71
LEU
106
A
LEU
107
n
72
LEU
107
A
ASN
108
n
73
ASN
108
A
LEU
109
n
74
LEU
109
A
VAL
110
n
75
VAL
110
A
TYR
111
n
76
TYR
111
A
GLU
112
n
77
GLU
112
A
THR
113
n
78
THR
113
A
THR
114
n
79
THR
114
A
ASP
115
n
80
ASP
115
A
LYS
116
n
81
LYS
116
A
HIS
117
n
82
HIS
117
A
LEU
118
n
83
LEU
118
A
SER
119
n
84
SER
119
A
PRO
120
n
85
PRO
120
A
ASP
121
n
86
ASP
121
A
GLY
122
n
87
GLY
122
A
GLN
123
n
88
GLN
123
A
TYR
124
n
89
TYR
124
A
VAL
125
n
90
VAL
125
A
PRO
126
n
91
PRO
126
A
ARG
127
n
92
ARG
127
A
ILE
128
n
93
ILE
128
A
MET
129
n
94
MET
129
A
PHE
130
n
95
PHE
130
A
VAL
131
n
96
VAL
131
A
ASP
132
n
97
ASP
132
A
PRO
133
n
98
PRO
133
A
SER
134
n
99
SER
134
A
LEU
135
n
100
LEU
135
A
THR
136
n
101
THR
136
A
VAL
137
n
102
VAL
137
A
ARG
138
n
103
ARG
138
A
ALA
139
n
104
ALA
139
A
ASP
140
n
105
ASP
140
A
ILE
141
n
106
ILE
141
A
THR
142
n
107
THR
142
A
GLY
143
n
108
GLY
143
A
ARG
144
n
109
ARG
144
A
TYR
145
n
110
TYR
145
A
SER
146
n
111
SER
146
A
ASN
147
n
112
ASN
147
A
ARG
148
n
113
ARG
148
A
LEU
149
n
114
LEU
149
A
TYR
150
n
115
TYR
150
A
ALA
151
n
116
ALA
151
A
TYR
152
n
117
TYR
152
A
GLU
153
n
118
GLU
153
A
PRO
154
n
119
PRO
154
A
ALA
155
n
120
ALA
155
A
ASP
156
n
121
ASP
156
A
THR
157
n
122
THR
157
A
ALA
158
n
123
ALA
158
A
LEU
159
n
124
LEU
159
A
LEU
160
n
125
LEU
160
A
LEU
161
n
126
LEU
161
A
ASP
162
n
127
ASP
162
A
ASN
163
n
128
ASN
163
A
MET
164
n
129
MET
164
A
LYS
165
n
130
LYS
165
A
LYS
166
n
131
LYS
166
A
ALA
167
n
132
ALA
167
A
LEU
168
n
133
LEU
168
A
LYS
169
n
134
LYS
169
A
LEU
170
n
135
LEU
170
A
LEU
171
n
136
LEU
171
A
LYS
172
n
137
LYS
172
A
THR
173
n
138
THR
173
A
GLU
174
n
139
GLU
174
A
LEU
175
n
140
LEU
175
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
O
VAL
105
A
O
VAL
70
A
N
MET
73
A
N
MET
38
A
N
LEU
72
A
N
LEU
37
A
O
VAL
131
A
O
VAL
96
A
N
HIS
77
A
N
HIS
42
A
O
LEU
109
A
O
LEU
74
5
A
A
HH21
OD2
ARG
ASP
127
140
1.59
1
A
LEU
44
69.91
-69.37
1
A
ARG
46
64.40
91.56
1
A
LEU
52
62.17
-94.84
1
A
ILE
53
171.73
-34.46
1
A
TRP
54
75.05
-48.38
1
A
PRO
82
-37.00
122.86
1
A
TYR
111
-179.95
119.26
1
A
GLU
112
70.05
118.33
1
A
THR
114
-119.17
78.48
1
A
TYR
124
171.40
151.76
1
A
PRO
126
-66.26
-146.78
1
A
ARG
127
171.50
-43.09
1
A
THR
136
-124.29
-166.21
1
A
ASN
147
-158.21
55.74
1
A
ARG
148
75.16
139.80
1
A
PRO
154
-42.08
-17.13
1
A
LEU
160
-39.49
-35.66
1
A
LYS
169
58.08
-73.64
1
A
THR
173
78.37
-55.06
2
A
LEU
44
-147.94
-50.75
2
A
SER
45
73.51
129.62
2
A
THR
55
66.38
87.44
2
A
ASN
69
54.28
82.08
2
A
GLU
80
-85.48
33.67
2
A
VAL
110
-90.03
47.53
2
A
TYR
111
79.64
80.10
2
A
GLU
112
-151.10
-76.26
2
A
THR
114
-156.70
25.27
2
A
PRO
126
-25.70
100.42
2
A
ARG
127
-163.07
-162.74
2
A
ALA
139
-113.52
67.51
2
A
ARG
148
45.64
90.06
2
A
TYR
152
-113.55
-129.59
2
A
GLU
153
52.99
165.94
2
A
THR
173
-45.90
152.92
3
A
ASP
37
65.73
106.29
3
A
GLN
42
68.52
174.26
3
A
ASP
50
67.46
-172.94
3
A
LEU
52
68.08
-86.76
3
A
GLU
112
-157.54
-53.36
3
A
VAL
125
-85.27
-75.64
3
A
PRO
126
-47.77
93.17
3
A
ARG
127
174.44
-177.06
3
A
LEU
135
70.27
67.22
3
A
ALA
139
-90.28
57.00
3
A
TYR
152
-156.20
10.37
3
A
ASP
156
-76.49
23.28
3
A
LYS
172
-159.90
71.29
4
A
SER
45
70.43
78.28
4
A
TRP
54
-73.02
-71.94
4
A
LYS
95
-43.42
-18.92
4
A
PHE
104
-120.21
-166.08
4
A
VAL
110
169.26
-48.61
4
A
THR
113
72.95
73.46
4
A
LEU
118
-91.71
32.20
4
A
SER
119
52.47
87.90
4
A
PRO
126
-38.08
108.80
4
A
MET
129
-105.32
-169.60
4
A
PRO
133
-48.70
-16.49
4
A
ALA
139
-111.43
-79.15
4
A
ARG
144
-87.95
-139.01
4
A
GLU
153
110.14
164.28
4
A
LYS
169
75.76
-68.64
4
A
LYS
172
44.76
84.87
5
A
ASP
37
73.80
112.50
5
A
PHE
39
64.11
87.18
5
A
TRP
48
68.86
-63.96
5
A
GLN
51
58.24
83.05
5
A
ASN
69
68.77
-9.34
5
A
THR
113
-85.76
46.81
5
A
ARG
127
-175.38
148.32
5
A
PRO
133
-59.87
-8.26
5
A
LEU
135
153.13
13.18
5
A
ALA
139
69.53
-22.57
5
A
ASP
140
68.13
102.01
5
A
THR
142
-69.26
-174.38
5
A
GLU
153
47.70
178.87
5
A
PRO
154
-58.00
-0.53
5
A
LYS
172
62.29
99.65
5
A
GLU
174
-142.64
-59.19
6
A
PHE
39
66.35
93.19
6
A
PRO
41
-73.64
-153.94
6
A
LEU
44
63.67
74.07
6
A
ASP
50
71.99
158.50
6
A
TYR
58
-78.46
-71.26
6
A
ASN
69
119.49
62.21
6
A
PRO
82
-38.76
123.10
6
A
VAL
110
-171.98
-16.48
6
A
TYR
111
-78.15
-73.15
6
A
THR
113
175.72
-77.57
6
A
THR
114
59.16
79.89
6
A
VAL
125
-40.97
165.58
6
A
PRO
126
-7.91
92.06
6
A
ALA
139
-53.87
89.44
6
A
ARG
144
80.25
177.27
6
A
ASN
147
-59.34
3.35
6
A
ARG
148
-169.98
24.52
6
A
LEU
171
-160.61
86.28
6
A
LYS
172
49.22
87.12
6
A
THR
173
-99.54
-83.83
7
A
ARG
46
-175.21
-17.54
7
A
GLN
51
-89.77
-76.64
7
A
ASN
69
63.51
75.18
7
A
ASP
79
-90.57
-67.31
7
A
GLU
112
-85.00
-157.25
7
A
PRO
133
-56.31
-8.56
7
A
ASP
140
-145.13
-51.20
7
A
ASN
147
172.85
111.82
7
A
ARG
148
88.25
89.14
7
A
LYS
169
-149.45
44.47
8
A
TRP
48
-77.77
-83.84
8
A
TRP
54
-68.04
94.25
8
A
THR
57
70.81
114.83
8
A
PHE
104
-119.89
-165.75
8
A
VAL
110
-126.84
-63.43
8
A
VAL
125
-52.82
107.47
8
A
ARG
127
64.73
-88.61
8
A
THR
136
74.10
-177.22
8
A
ASP
140
44.51
98.46
8
A
ARG
148
-162.46
92.19
9
A
ASP
37
66.59
102.24
9
A
PRO
41
-57.45
-70.41
9
A
GLN
42
-157.96
-51.43
9
A
THR
43
58.75
82.84
9
A
ARG
46
65.32
178.20
9
A
THR
113
61.87
85.80
9
A
SER
119
50.81
93.11
9
A
PRO
126
-66.66
95.36
9
A
ARG
127
-173.34
-176.05
9
A
THR
136
-172.32
139.04
9
A
THR
142
-178.81
-172.98
9
A
ASN
147
-160.93
75.65
9
A
ARG
148
39.85
74.38
9
A
LYS
169
67.50
-168.71
10
A
GLN
42
-178.39
-33.77
10
A
LEU
44
64.98
74.16
10
A
SER
45
-140.54
21.47
10
A
TRP
48
68.69
149.51
10
A
ASP
50
-166.52
95.53
10
A
ILE
53
62.41
83.38
10
A
GLU
80
-77.99
35.89
10
A
SER
119
177.04
147.33
10
A
ASP
121
-75.75
32.91
10
A
VAL
125
-95.24
-119.42
10
A
PRO
126
-11.57
83.37
10
A
ASN
147
-57.24
-84.27
10
A
PRO
154
-39.65
-19.31
lowest energy, model 1
Solution structure of E60A mutant AGR2
1
N
N
A
THR
57
A
THR
22
HELX_P
A
SER
68
A
SER
33
1
1
12
A
HIS
83
A
HIS
48
HELX_P
A
ALA
92
A
ALA
57
1
2
10
A
ASN
94
A
ASN
59
HELX_P
A
GLN
103
A
GLN
68
1
3
10
A
GLU
153
A
GLU
118
HELX_P
A
ALA
155
A
ALA
120
5
4
3
A
ASP
156
A
ASP
121
HELX_P
A
LYS
169
A
LYS
134
1
5
14
CELL ADHESION
Thioredoxin-fold, cancer, adhesion, metastasis, CELL ADHESION
AGR2_HUMAN
UNP
1
41
O95994
PQTLSRGWGDQLIWTQTYEEALYKSKTSNKPLMIIHHLDECPHSQALKKVFAENKEIQKLAEQFVLLNLVYETTDKHLSP
DGQYVPRIMFVDPSLTVRADITGRYSNRLYAYEPADTALLLDNMKKALKLLKTEL
41
175
2LNT
41
175
O95994
A
1
6
140
1
expression tag
ILE
36
2LNT
A
O95994
UNP
1
1
expression tag
ASP
37
2LNT
A
O95994
UNP
2
1
expression tag
PRO
38
2LNT
A
O95994
UNP
3
1
expression tag
PHE
39
2LNT
A
O95994
UNP
4
1
expression tag
THR
40
2LNT
A
O95994
UNP
5
1
GLU
engineered mutation
ALA
60
2LNT
A
O95994
UNP
60
25
3
2
parallel
anti-parallel
parallel
A
VAL
105
A
VAL
70
A
LEU
106
A
LEU
71
A
LEU
72
A
LEU
37
A
MET
73
A
MET
38
A
PHE
130
A
PHE
95
A
VAL
131
A
VAL
96
A
HIS
76
A
HIS
41
A
HIS
77
A
HIS
42
A
LEU
109
A
LEU
74
A
VAL
110
A
VAL
75